Ecklonia cava (EC) is a member of the family Laminariaceae, and it is an edible marine
brown alga with various bioactivities. Five phlorotannin derivatives from the methanol extract …

In the last three decades the discovery of metabolites with biological activities from
macroalgae has increased significantly. However, despite the intense research effort by …

Separating individual compounds by HPLC represents an effective method for the detection
and quantification of phenolic compounds and has been widely utilised. However …

Phaeophyceae (brown algae) essentially contribute to biotopes of cold and temperate seas.
Their thalli are rich in biologically active natural products, which are strongly and universally …

The ineffectiveness of traditional cancer therapies due to drug resistance, nontargeted
delivery, and chemotherapy‐associated adverse side effects has shifted attention to …

Marine-derived natural products are rich source of secondary metabolites with huge
potentials including novel therapeutic agents. Marine algae are considered to be a good …

Recently, a great deal of interest has been developed to isolate novel bioactive compounds
from marine resources because of their numerous health beneficial effects. Among marine …

Bioprospecting for seaweed-derived multimodal acting products have earned increasing
attention in the fight against diseases of multifactorial origin, such as neurodegenerative …

Seaweeds are a potential source of bioactive compounds that are useful for
biotechnological applications and can be employed in different industrial areas in order to …

The brown seaweed Ecklonia cava is known to be a rich source of phlorotannins that have
diverse biological activities. Among the phlorotannins in E. cava, concentrations of dieckol …